Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01400893 · ClinicalTrials.gov registry record · NA
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A NA study, sponsored by SeaStar Medical.
- Terminated
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT01400893 is a NA study that was terminated before completion, run by SeaStar Medical. The registered enrollment target is 134 participants.
The verdict
NCT01400893, a NA study, was terminated before completion, sponsored by SeaStar Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
The purpose of this protocol is to evaluate the safety of a selective cytopheretic device (SCD) in patients that are on continuous renal replacement therapy (CRRT) for acute kidney injury (AKI).
Interventions
- DEVICE SCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01400893
The ClinicalTrials.gov registry entry for NCT01400893 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SeaStar Medical, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SCD is the first listed.
NCT01400893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01400893 about?
NCT01400893 is a clinical study titled "Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury". The purpose of this protocol is to evaluate the safety of a selective cytopheretic device (SCD) in patients that are on continuous renal replacement therapy (CRRT) for acute kidney injury (AKI).
What is the current status of trial NCT01400893?
This trial is currently terminated. It is a NA study. The enrollment target is 134 participants. The study started on 2011-08. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01400893?
The interventions under investigation include: SCD (DEVICE).
Who is sponsoring clinical trial NCT01400893?
This trial is sponsored by SeaStar Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.